Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver

Hepatology

Volumn 24, Issue 1, 1996, Pages 241-247

  Kuipers, Folkert ^a,d   Van Ree, Janine M ^b   Hofker, Marten H ^c   Wolters, Henk ^a   Veld, Gerda In't ^a   Havinga, Rick ^a   Vonk, Roel J ^a   Princen, Hans M G ^b   Havekes, Louis M ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b TNO   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BILE ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LATHOSTEROL; LIPID; LIVER ENZYME; MESSENGER RNA; PHOSPHOLIPID; STEROL 27 HYDROXYLASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE SECRETION; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029893226     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008707269     Document Type: Article

References (59)

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
2. Mahley RW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis Biochim Biophys Acta 1983;737:197-222.
3. Ji Z-S, Fazio S, Lee Y-L, Mahley RW. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J Biol Chem 1994;269:2764-2772.
4. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 1985; 76:1501-1513.
5. Pitas RE, Boyles JK, Lee SH, Hui DY, Weisgraber KH. Lipoproteins and their receptors in the central nervous system: characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E (LDL) receptors in the brain. J Biol Chem 1987;262:14352-14360.
6. Schwiegelshohn B, Presley JF, Gorecki M, Vogel T, Carpentier YA, Maxfield FR, Deckelbaum RJ. Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake. J Biol Chem 1995;270:1761-1769.
7. Mahley RW, Rall SC Jr. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. Ed 6. New York: McGraw-Hill, 1989:1195-1213.
8. Schaefer EJ, Gregg RE, Ghiselli G, Forte TM, Ordovas JM, Zech LA, Brewer Jr HB. Familial apolipoprotein E deficiency. J Clin Invest 1986; 78:1206-1219.
9. Mabuchi H, Itoh H, Takeda M, Kajinami K, Wakasugi T, Koizumi J, Takeda R, et al. A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency. Metabolism 1989;38:115-119.
10. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987;80:578-581.
11. Kempen HJM, Gevers Leuven JA, van der Voort HA, de Knijff P, Havekes L. Lathosterol level in plasma is elevated in type III hyperlipoproteinemia, but not in non-type III subjects with apolipoprotein E2/2 phenotype, nor in type IIa or IIb hyperlipoproteinemia. Metabolism 1991;40:231-235, 1991.
12. Björkhem I, Miettinen TA, Reihner E, Ewerth S, Angelin B, Einarsson K. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res 1987;28:1137-1143.
13. Kempen HJM, Glatz JFC, Gevers Leuven JA, van der Voort HA, Katan MB. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 1988;29:1149-1155.
14. Angelin B, Holmquist L, Leijd B, Einarsson K. Bile acid metabolism in familial dysbetalipoproteinemia: studies in subjects with the apolipoprotein E-2/2 phenotype. Eur J Clin Invest 1990;20:143-149.
15. Juvonen T, Kervinen K, Kairaluoma MI, Lajunen LHJ, Kesäniemi YA. Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology 1993;104:1806-1813.
16. Packard CJ, Sheperd J. The hepatobiliary axis and lipoprotein metabolism: effects of bile acid sequestrants and ileal bypass surgery. J Lipid Res 1982;23:1081-1098.
17. van Ree JH, van den Broek WJAA, Dahlmans VEH, Groot PHE, Vidgeon-Hart M, Frants RR, Wieringa B, et al. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis 1994;111:25-37.
18. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;258:468-471.
19. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343-353.
20. Wolthers BG, Walrecht HT, van der Molen JC, Nagel GT, van Doormaal JJ, Wijnandts PM. Use of determinations of 7-lathosterol (5-alpha-cholest-7-en-3-beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. J Lipid Res 1991;32:603-612.
21. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can Biochem Biophys 1959;37:911-917.
22. Smit MJ, Temmerman AM, Havinga R, Kuipers F, Vonk RJ. Short- and long-term effects of biliary drainage on hepatic cholesterol metabolism in the rat. Biochem J 1991;269:781-788.
23. Kuipers F, Spanjer HH, Havinga R, Scherphof GL, Vonk RJ. Lipoproteins and liposomes as in vivo cholesterol vehicles in the rat: preferential use of cholesterol carried by small unilamellar liposomes for the formation of muricholic acids. Biochim Biophys Acta 1986;876:559-566.
24. Gamble W, Vaughan M, Kruth MS, Avignan J. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res 1978;19:1068-1071.
25. Böttcher CFJ, van Gent CM, Pries C. A rapid and sensitive sub-micro phosphorus determination. Anal Chim Acta 1961;24:203-204.
26. Twisk J, Lehmann EM, Princen HMG. Differential feedback regulation of cholesterol 7α-hydroxylase mRNA and transcriptional activity by bile acids in primary monolayer cultures of rat hepatocytes. Biochem J 1993; 290:685-691.
27. 3: gonadotropic regulation of the cognate mRNA in ovaries. DNA Cell Biol 1990;9:657-665.
28. Andersson S, Davis DL, Dahlbäck H, Jörnvall H, Russell DW. Cloning, structure and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem 1989;264:8222-8229.
29. Chin DW, Gil G, Russell DW, Liscum L, Luskey KL, Basu SK, Okayama H, et al. Nucleotide sequence of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase, a glycoprotein of endoplasmic reticulum. Nature 1984;308:613-617.
30. Lee LY, Mohler WA, Schafer BL, Freudenberger JS, Byrne-Connolly N, Eager KB, Mosley ST, et al. Nucleotide sequence of the rat low density lipoprotein receptor cDNA. Nucleic Acids Res 1989;17:1259-1260.
31. Smit MJ, Temmerman AM, Wolters H, Kuipers F, Beynen AC, Vonk RJ. Dietary fish oil-induced changes in intrahepatic cholesterol transport and bile acid synthesis in rats. J Clin Invest 1991;88:943-951.
32. Philipp BW, Shapiro DJ. Improved methods for the assay and activation of 3-hydroxy-3-methylglutaryl Coenzyme A reductase. J Lipid Res 1979; 20:588-593.
33. Billheimer JT, Tavani D, Nes WR. Effect of dispersion of cholesterol in Triton WR-1339 on acyl CoA:cholesterol acyltransferase in rat liver microsomes. Anal Biochem 1981;111:331-335.
34. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin reagent. J Biol Chem 1951;193:265-275.
35. Axelsson M, Sjövall J. Potential bile acid precursors in plasma-possible indicators of biosynthetic pathways to cholic and chnodeoxycholic acids in man. J Steroid Biochem 1990;36:631-640.
36. Princen HMG, Meijer P, Wolthers BG, Vonk RJ, Kuipers F. Cyclosporine A blocks bile acid synthesis in cultured hepatocytes by specific inhibition of chenodeoxycholic acid synthesis. Biochem J 1991;275:501-505.
37. Twisk J, de Wit E, Princen HMG. Suppression of sterol 27-hydroxylase mRNA and transcriptional activity by bile acids in cultured rat hepatocytes. Biochem J 1995;305:505-511.
38. Verkade HJ, Vonk RJ, Kuipers F. New insights into the mechanism of bile acid-induced biliary lipid secretion. HEPATOLOGY 1995;21:1174-1189.
39. Oude Elferink RPJ, Ottenhof R, van Wijland M, Smit JMM, Schinkel AH, Groen AK. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J Clin Invest 1995;95:31-38.
40. Quarfordt SH, Oswald B, Landis B, Xu HS, Zhang SH, Maeda N. In vivo cholesterol kinetics in apolipoprotein E-deficient and control mice. J Lipid Res 1995;36:1227-1235.
41. Björkhem I. Mechanism of bile acid biosynthesis in mammalian liver. In: Danielsson H, Sjövall J, eds. New comprehensive biochemistry. Vol 12. Sterols and Bile Acids. Amsterdam: Elsevier, 1985:231-272.
42. Björkhem I, Akerlund JE. Studies on the link between HMG-CoA reductase and cholesterol 7α-hydroxylase in rat liver. J Lipid Res 1988;29:136-143.
43. Björkhem I. Effects of mevinolin in rat liver: evidence for a lack of coupling between synthesis of hydroxymethylglutaryl-CoA-reductase and cholesterol 7α-hydroxylase activity. Biochim Biophys Acta 1986;877:43-49.
44. Singer II, Kawka DW, Kazazis DM, Alberts AW, Chen JS, Huff JW, Ness GC. Hydroxymethylglutaryl-coenzyme A reductase-containing hepatocytes are distributed periportally in normal and mevinolin-treated rat livers. Proc Natl Acad Sci U S A 1984;81:5556-5560.
45. Li AC, Tanaka RD, Callaway K, Fogelman AM, Edwards PA. Localization of 3-hydroxy-3-methylglutaryl CoA reductase and 3-hydroxy-3-methylglutaryl CoA synthase in the rat liver and intestine is affected by cholestyramine and mevinolin. J Lipid Res 1988;29:781-796.
46. Twisk J, Hoekman MFM, Mager WH, Moorman AFM, de Boer PAJ, Scheja L, Princen HMG, et al. Heterogeneous expression of cholesterol 7α-hydroxylase and sterol 27-hydroxylase genes in the rat liver lobulus. J Clin Invest 1995;95:1235-1243.
47. Ugele B, Kempen HJM, Gebhardt R, Meijer P, Burger HJ, Princen HMG. Heterogeneity of rat liver parenchyma in cholesterol 7α-hydroxylase and bile acid synthesis. Biochem J 1991;276:73-77.
48. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, Mol CAAM, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to complete absence of phospholipid from bile and to liver disease. Cell 1993;75:451-462.
49. Smit MJ, Verkade HJ, Havinga R, Vonk RJ, Scherphof GL, In't Veld G, Kuipers F. Dietary fish oil potentiates bile acid-induced cholesterol secretion in rats. J Lipid Res 1994;35:301-310.
50. Turley SD, Dietschy JM. The contribution of newly synthetized cholesterol to biliary cholesterol in the rat. J Biol Chem 1981;256:2438-2446.
51. Turley SD, Spady DK, Dietschy JM. Alteration of the degree of biliary cholesterol saturation in the hamster and rat by manipulation of the pools of preformed and newly synthesized cholesterol. Gastroenterology 1983; 84:253-264.
52. Robins SJ, Fasulo JM, Lessard PD, Patton GM. Changes in biliary lipid secretion during normal development and diurnal cycling in the rat. J Lipid Res 1993;34:1445-1450.
53. Duane WC, Hunninghake DB, Freeman ML, Pooler PA, Schlasner LA, Gebhard RL. Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile. HEPATOLOGY 1988; 8:1147-1150.
54. Mitchell JC, Stone BG, Logan GM, Duane WC. Role of cholesterol synthesis in the regulation of bile acid synthesis and biliary cholesterol secretion in humans. J Lipid Res 1991;32:1143-1149.
55. Bilhartz LE, Spady DK, Dietschy JM. Inappropriate hepatic cholesterol synthesis expands the cellular pool of sterol available for recruitment by bile acids in the rat. J Clin Invest 1989;84:1181-1187.
56. Suckling KE, Stange EF. Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism. J Lipid Res 1985;26:647-671.
57. Lombardi P, Mulder M, van der Boom H, Frants RR, Havekes LM. Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment. J Biol Chem 1993; 268:26113-26119.
58. Tabas I, Myers JN, Innerarity TL, Xu X-X, Arnold K, Boyles J, Maxfield FR. The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targetting of β-VLDL in mouse peritoneal macrophages. J Cell Biol 1991;115:1547-1560.
59. Fungwe TV, Cagen LM, Cook GA, Wilcox HG, Heimberg M. Dietary cholesterol stimulates hepatic biosynthesis of triglyceride and reduces oxidation of fatty acids in the rat. J Lipid Res 1993;34:933-941.